A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)

NCT00067743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Complex Regional Pain Syndrome (RSD)

Interventions

DRUG: Lenalidomide

Sponsor

Celgene Corporation